Primary efficacy and safety of adalimumab in nail psoriasis from the first 26weeks of a phase-3, randomized, placebo-controlled trial with subanalysis in patients with and without psoriatic arthritis

被引：0
|
作者：
Elewski, Boni E. [1 ]
Rich, Phoebe A. [2 ]
Behrens, Frank [3 ]
Guillet, Gerard [4 ]
Geng, Ziqian [5 ]
Servin, Ofelia Reyes [5 ]
机构：
[1] Univ Alabama Birmingham, Sch Med, Birmingham, AL USA
[2] Oregon Hlth & Sci Univ Hosp, Portland, OR USA
[3] Goethe Univ, Med Ctr, Frankfurt, Germany
[4] CHU Poitiers, Serv Dermatol, Hop Mil, Poitiers, France
[5] AbbVie Inc, N Chicago, IL USA
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2017年 / 76卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
5081
引用
收藏
页码：AB204 / AB204
页数：1
相关论文
共 50 条
  • [31] Efficacy and Safety of Adalimumab among Patients with Moderate to Severe Psoriasis with Co-MorbiditiesSubanalysis of Results from a Randomized, Double-Blind, Placebo-Controlled, Phase III Trial
    Alexa B. Kimball
    Arielle G. Bensimon
    Annie Guerin
    Andrew P. Yu
    Eric Q. Wu
    Martin M. Okun
    Yanjun Bao
    Shiraz R. Gupta
    Parvez M. Mulani
    [J]. American Journal of Clinical Dermatology, 2011, 12 : 51 - 62
  • [32] EFFICACY OF GUSELKUMAB ACROSS BASDAI COMPONENTS IN TREATING AXIAL-RELATED SYMPTOMS OF PSORIATIC ARTHRITIS: RESULTS FROM TWO PHASE-3, RANDOMIZED, PLACEBO-CONTROLLED STUDIES
    Behrens, F.
    Mease, P. J.
    Helliwell, P. S.
    Shawi, M.
    Noel, W.
    Chakravarty, S. D.
    Kollmeier, A. P.
    Xu, X. L.
    Xu, S.
    Wang, Y.
    Baraliakos, X.
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2021, 39 (05) : 1244 - 1245
  • [33] Adalimumab for the treatment of patients with moderately to severely active psoriatic arthritis - Results of a double-blind, randomized, placebo-controlled trial
    Mease, PJ
    Gladman, DD
    Ritchlin, CT
    Ruderman, EM
    Steinfeld, SD
    Choy, EHS
    Sharp, JT
    Ory, PA
    Perdok, RJ
    Weinberg, MA
    [J]. ARTHRITIS AND RHEUMATISM, 2005, 52 (10): : 3279 - 3289
  • [34] Leflunomide in the treatment of psoriatic arthritis and psoriasis: Data from a double-blind, randomized, placebo-controlled clinical trial
    Kaltwasser, J
    Nash, P
    Gladman, D
    Rosen, C
    Behrens, F
    Mease, P
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 : 90 - 90
  • [35] EFFICACY AND SAFETY OF FILGOTINIB, A SELECTIVE JANUS KINASE 1 INHIBITOR, IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS: SUBGROUP ANALYSES FROM A RANDOMIZED, PLACEBO-CONTROLLED, PHASE 2 TRIAL (EQUATOR)
    Helliwell, P.
    Van den Bosch, F.
    Coates, L. C.
    Gladman, D. D.
    Tasset, C.
    Meuleners, L.
    Gilles, L.
    Gheyle, L.
    Trivedi, M.
    Alani, M.
    Besuyen, R.
    Mease, P. J.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 761 - 762
  • [36] Secukinumab Provides Sustained Improvements in Psoriatic Arthritis: 2-Year Efficacy and Safety Results from a Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial
    Mease, Philip J.
    McInnes, Iain B.
    Kirkham, Bruce
    Kavanaugh, Arthur
    Rahman, Proton
    van der Heijde, Desiree
    Landewe, Robert B. M.
    Nash, P.
    Pricop, Luminita
    Wang, Zailong
    Mpofu, Shephard
    [J]. ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [37] Efficacy and safety of Adalimumab in patients with moderate to severe hidradenitis suppurativa: results from PIONEER II, a phase 3 randomised placebo-controlled trial
    Herra, L. Escudero
    Jemec, G. B. E.
    Gottlieb, A.
    Forman, S.
    Giamarellos-Bourboulis, E. J.
    Reguiai, Z.
    Gu, Y.
    Okun, M. M.
    [J]. AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2015, 56 : 34 - 35
  • [38] A Randomized, Double-blind, Active-and Placebo-controlled Phase 3 Study of Efficacy and Safety of Ixekizumab, Adalimumab, and Placebo Therapy in Patients Naive to Biologic Disease Modifying Antirheumatic Drugs with Active Psoriatic Arthritis
    Mease, Philip
    van der Heijde, Desiree
    Ritchlin, Christopher
    Cuchacovich, Raquel
    Shuler, Catherine
    Lin, Chen-Yen
    Vangerow, Harald
    Samanta, Suvajit
    Lee, Chin
    Gladman, Dafna
    [J]. JOURNAL OF RHEUMATOLOGY, 2016, 43 (06) : 1169 - 1169
  • [39] Efficacy and safety results from a Phase 3, randomized, placebo-controlled trial of subcutaneous golimumab in Chinese patients with active rheumatoid arthritis despite methotrexate therapy
    Li, Zhanguo
    Zhang, Fengchun
    Kay, Jonathan
    Fei, Kaiyin
    Han, Chenglong
    Zhuang, Yanli
    Wu, Zhong
    Hsia, Elizabeth C.
    [J]. INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2016, 19 (11) : 1143 - 1156
  • [40] Safety and Efficacy Of Subcutaneous Golimumab In Chinese Patients With Active Rheumatoid Arthritis Despite MTX Therapy: Results From a Randomized, Placebo-Controlled, Phase 3 Trial
    Li, Zhanguo
    Zhang, Fengchun
    Kay, Jonathan
    Fei, Kaiyin
    Han, Chenglong
    Zhuang, Yanli
    Wu, Zhong
    Hsia, Elizabeth C.
    [J]. ARTHRITIS AND RHEUMATISM, 2013, 65 : S598 - S599
12345